These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1831 related articles for article (PubMed ID: 26275105)

  • 21. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
    Muller M; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.
    Tudur Smith C; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2001; (4):CD001769. PubMed ID: 11687121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbamazepine versus phenobarbitone monotherapy for epilepsy.
    Tudur Smith C; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2003; (1):CD001904. PubMed ID: 12535420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
    Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamazepine versus phenytoin monotherapy for epilepsy.
    Tudur Smith C; Marson AG; Clough HE; Williamson PR
    Cochrane Database Syst Rev; 2002; (2):CD001911. PubMed ID: 12076427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamotrigine versus carbamazepine monotherapy for epilepsy.
    Gamble CL; Williamson PR; Marson AG
    Cochrane Database Syst Rev; 2006 Jan; (1):CD001031. PubMed ID: 16437428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.
    Taylor S; Tudur Smith C; Williamson PR; Marson AG
    Cochrane Database Syst Rev; 2001; (4):CD002217. PubMed ID: 11687150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregabalin monotherapy for epilepsy.
    Zhou Q; Zheng J; Yu L; Jia X
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009429. PubMed ID: 23076957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clobazam monotherapy for focal or generalized seizures.
    Arya R; Giridharan N; Anand V; Garg SK
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009258. PubMed ID: 29995989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.
    Leone MA; Giussani G; Nevitt SJ; Marson AG; Beghi E
    Cochrane Database Syst Rev; 2021 May; 5(5):CD007144. PubMed ID: 33942281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD005612. PubMed ID: 35349176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes.
    Tan HJ; Singh J; Gupta R; de Goede C
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006779. PubMed ID: 25190506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clobazam monotherapy for partial-onset or generalized-onset seizures.
    Arya R; Anand V; Garg SK; Michael BD
    Cochrane Database Syst Rev; 2014 Oct; (10):CD009258. PubMed ID: 25280512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD011501. PubMed ID: 35285519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Hemming K; Marson AG
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.
    Leone MA; Giussani G; Nolan SJ; Marson AG; Beghi E
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD007144. PubMed ID: 27150433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007783. PubMed ID: 32609387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.
    Mbizvo GK; Dixon P; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD001901. PubMed ID: 22972056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001909. PubMed ID: 27329345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 92.